About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Epilepsy Clinical Trials in Phoenix | 100 Studies

Clinical Trials EpilepsyPhoenix

Epilepsy Clinical Trials in Phoenix

Find 100 clinical trials for epilepsy near Phoenix, Arizona. Connect with research centers in your area.

All Epilepsy trials nationwide All trials in Phoenix

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 100 trials

CompletedRandomized Therapy In Status EpilepticusThis study evaluated the effectiveness and safety of an investigational product (IP), intravenous (IV) ganaxolone, to treat participants with status epilepticus (SE).NCT04391569·Birmingham, Alabama and 73 others

Epilepsy Trials in Other Cities

New York Los Angeles Chicago Houston Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedDetermine Safety and Efficacy of Long-term Oral Lacosamide in Patients With Partial SeizuresThe purpose of this trial is to determine whether lacosamide is safe and effective for long-term use in patients with partial-seizures from epilepsyNCT00522275·Birmingham, Alabama and 59 others

CompletedTo Determine Tolerability and Efficacy of Long-term Oral Lacosamide in Patients With Partial SeizuresThe purpose of this trial is to determine whether lacosamide is safe and effective for long-term use in patients with partial-seizures from epilepsy.NCT00552305·Birmingham, Alabama and 58 others

Active not recruitingStudy to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset EpilepsyThe purpose of this study is to determine whether BHV-7000 is effective in the treatment of refractory focal epilepsy.NCT06309966·Peoria, Arizona and 149 others

CompletedStudy Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial SeizuresThis study is being conducted to compare the efficacy and safety of LAMICTAL (lamotrigine) extended-release with placebo in the treatment of partial seizures.NCT00113165·Anniston, Alabama and 147 others

CompletedChildhood Absence Epilepsy Rx PK-PD-Pharmacogenetics StudyThe purpose of this study is to determine the best initial treatment for childhood absence epilepsy.NCT00088452·Birmingham, Alabama and 30 others

CompletedSafety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset SeizuresThis is a multicenter, open label study to assess the safety and pharmacokinetics of YKP3089 as adjunctive therapy in subjects with partial onset seizures.NCT02535091·Phoenix, Arizona and 120 others

TerminatedFeasibility Study on LITT for Medical Refractory EpilepsyMulticenter, open-label, prospective designed study to characterize the performance of brain laser interstitial thermal therapy (LITT) ablation using the Monteris NeuroBlate…NCT02820740·Phoenix, Arizona and 4 others

CompletedStudy to Investigate Dosage, Efficacy, and Safety of Fycompa in Routine Clinical Care of Patients With EpilepsyThis study is conducted to assess the retention rate of Fycompa when given in routine clinical care.NCT03208660·Phoenix, Arizona and 43 others

CompletedConversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial EpilepsyThis study is being conducted to determine the effectiveness of a lower monotherapy dose of lamotrigine than that currently approved.NCT00355082·Alabaster, Alabama and 102 others

CompletedEfficacy and Safety of GWP42003-P for Seizures Associated With Lennox-Gastaut Syndrome in Children and AdultsThe primary objective of this study was to evaluate the efficacy of GWP42003-P as adjunctive treatment in reducing the number of drop seizures when compared with placebo in…NCT02224560·Birmingham, Alabama and 28 others

WithdrawnENACT: A Study of ENX-101 as Adjunctive Treatment in Patients With Focal SeizuresThe ENACT trial is designed to evaluate the efficacy and safety of ENX-101 administered adjunctively to current therapy in reducing seizure frequency in patients diagnosed with…NCT05481905·Phoenix, Arizona and 37 others

CompletedA 19-week Cognition Study of Levetiracetam in Children With Partial Onset SeizuresA 12-week Evaluation Period will be used to characterize potential cognitive and neuropsychological effects of LEV (20 - 60 mg/kg/day), as adjunctive treatment in children 4 - 16…NCT00105040·Birmingham, Alabama and 44 others

RecruitingRENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset SeizuresThis is a Phase 2 double-blind, randomized, placebo-controlled, multicenter, parallel-group study to evaluate the efficacy, safety, and tolerability of SPN-817 in adults with…NCT06798896·Phoenix, Arizona and 62 others

CompletedHeart Rate Changes During Normal Activity, Exercise, and Seizures in Subjects With EpilepsyCharacterization of the cardiac response (ECG) preceding an epileptic seizure.NCT01214707·Phoenix, Arizona and 1 other

CompletedStudy Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Primary Generalized Tonic-Clonic Seizures (PGTC) SeizuresThis study is being conducted to compare the efficacy and safety of LAMICTAL (lamotrigine) extended-release with placebo in the treatment of Primary Generalized Tonic-Clonic…NCT00104416·Anniston, Alabama and 145 others

CompletedRandomized, Double-Blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Therapy in PGTC SeizuresThis trial is intended to study the safety and effectiveness of an new anti-epileptic drug (AED) on Primary Generalized Tonic-Clonic (PGTC) Seizures.NCT03678753·Phoenix, Arizona and 115 others

CompletedStudy With Subjects 18-65 Years Old With Partial Onset Seizures Who Are Currently Taking LevetiracetamThis trial will evaluate the efficacy and safety of UCB44212 as add-on therapy in subjects with focal epilepsy.NCT00152503·Phoenix, Arizona and 16 others

CompletedA Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic EncephalopathiesThe purpose of this study is to investigate the effect on the frequency of all seizures (convulsive and drop) in participants treated with TAK-935 compared to placebo.NCT03650452·Phoenix, Arizona and 43 others

Enrolling by invitationLong-term Safety and Tolerability of BHV-7000A study to determine if BHV- 7000 is safe and tolerable in adults with refractory focal onset epilepsyNCT06443463·Birmingham, Alabama and 282 others

Page 1 of 5Next

Other Conditions in Phoenix

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia